NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

免疫組織化學(IHC)的全球市場:各產品(抗體,設備,套件,試劑),各用途(診斷及藥物檢驗)的市場調查,預測(∼2025年),COVID-19的累積性的影響

Immunohistochemistry Market Research Report by Product, by Application, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 995393
出版日期 內容資訊 英文 196 Pages
商品交期: 最快1-2個工作天內
價格
免疫組織化學(IHC)的全球市場:各產品(抗體,設備,套件,試劑),各用途(診斷及藥物檢驗)的市場調查,預測(∼2025年),COVID-19的累積性的影響 Immunohistochemistry Market Research Report by Product, by Application, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 196 Pages
簡介

全球免疫組織化學(IHC)的市場規模,預計從2020年的19億8,384萬美元,至2025年末為27億9,156萬美元成長。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。 本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。更新的調查,考慮市場上COVID-19的影響,提供洞察,分析,估計,及預測。

本報告提供免疫組織化學(IHC)的世界市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,各產品、用途、地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查考慮年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 產品預測
  • 用途預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各產品

  • 抗體
    • 一次抗體
    • 二次抗體
  • 設備
    • 幻燈片掃描機
    • 幻燈片染色系統
    • 組織微陣列
    • 組織處理系統
  • 套件
  • 試劑
    • 血清和試劑的定位掩護
    • 呈色受質
    • 稀釋劑
    • 固定試劑
    • 組織染色
    • 有機溶劑
    • 蛋白質分解酵素
    • 穩定劑

第7章 各用途

  • 診斷
    • 自體免疫疾病
    • 癌症
    • 心血管疾病
    • 糖尿病
    • 感染疾病
    • 腎臟疾病
  • 藥物檢驗

第8章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東、非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Abcam PLC
  • Agilent Technologies, Inc.
  • Bio SB, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biocare Medical, LLC
  • Biogenex Laboratories
  • Candor Bioscience GmbH
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Diagnostic BioSystems Inc.
  • Eagle Biosciences, Inc.
  • F. Hoffmann-La Roche AG
  • GenomeMe
  • Merck KGaA
  • Miltenyi Biotec
  • NeoGenomics Laboratories, Inc.
  • Perkinelmer, Inc.
  • Sakura Finetek Japan Co.,Ltd.
  • Sino Biological Inc.
  • Thermo Fisher Scientific, Inc.

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-A339DAEFADF4

The Global Immunohistochemistry Market size was estimated at USD 1,983.85 Million in 2020 and expected to reach USD 2,188.18 Million in 2021, at a Compound Annual Growth Rate (CAGR) 10.63% to reach USD 3,638.64 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Immunohistochemistry to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Immunohistochemistry Market was studied across Antibodies, Equipment, Kits, and Reagents. The Antibodies is further studied across Primary Antibodies and Secondary Antibodies. The Equipment is further studied across Slide Scanners, Slide Staining Systems, Tissue Microarrays, and Tissue Processing Systems. The Reagents is further studied across Blocking Sera and Reagents, Chromogenic Substrates, Diluents, Fixation Reagents, Histological Stains, Organic Solvents, Proteolytic Enzymes, and Stabilizers.

Based on Application, the Immunohistochemistry Market was studied across Diagnostics and Drug Testing. The Diagnostics is further studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, Diabetes Mellitus, Infectious Diseases, and Nephrological Diseases.

Based on End-user, the Immunohistochemistry Market was studied across Academic & Research Institutes, CROs, Forensic Labs, Hospitals & Diagnostic Laboratories, and Pharma & Biopharma Companies.

Based on Geography, the Immunohistochemistry Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Immunohistochemistry Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Immunohistochemistry Market, including Abcam PLC, Agilent Technologies, Inc., Bio SB, Inc., Bio-Rad Laboratories, Inc., Biocare Medical, LLC, Biogenex Laboratories, Candor Bioscience GmbH, Cell Signaling Technology, Inc., Danaher Corporation, Diagnostic BioSystems Inc., Eagle Biosciences, Inc., F. Hoffmann-La Roche AG, GenomeMe, Merck KGaA, Miltenyi Biotec, NeoGenomics Laboratories, Inc., Perkinelmer, Inc., Sakura Finetek Japan Co.,Ltd., Sino Biological Inc., and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Immunohistochemistry Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunohistochemistry Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunohistochemistry Market?
  • 4. What is the competitive strategic window for opportunities in the Global Immunohistochemistry Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Immunohistochemistry Market?
  • 6. What is the market share of the leading vendors in the Global Immunohistochemistry Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Immunohistochemistry Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Application Outlook
  • 3.5. End-user Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Extensive prevalence of chronic diseases such as cancer and autoimmune diseases among population
      • 5.1.1.2. Development of technologically advanced IHC solutions coupled with rising product approvals
      • 5.1.1.3. Increasing drug discoveries and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive setup and dearth of specificity in IHC solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Merging collaborations between pharmaceutical companies and players involved in IHC development
      • 5.1.3.2. Growing demand for personalized/customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns pertinent to product failure and shortage of skilled professionals
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Immunohistochemistry Market, by Product

  • 6.1. Introduction
  • 6.2. Antibodies
    • 6.2.1. Primary Antibodies
    • 6.2.2. Secondary Antibodies
  • 6.3. Equipment
    • 6.3.1. Slide Scanners
    • 6.3.2. Slide Staining Systems
    • 6.3.3. Tissue Microarrays
    • 6.3.4. Tissue Processing Systems
  • 6.4. Kits
  • 6.5. Reagents
    • 6.5.1. Blocking Sera and Reagents
    • 6.5.2. Chromogenic Substrates
    • 6.5.3. Diluents
    • 6.5.4. Fixation Reagents
    • 6.5.5. Histological Stains
    • 6.5.6. Organic Solvents
    • 6.5.7. Proteolytic Enzymes
    • 6.5.8. Stabilizers

7. Immunohistochemistry Market, by Application

  • 7.1. Introduction
  • 7.2. Diagnostics
    • 7.2.1. Autoimmune Diseases
    • 7.2.2. Cancer
    • 7.2.3. Cardiovascular Diseases
    • 7.2.4. Diabetes Mellitus
    • 7.2.5. Infectious Diseases
    • 7.2.6. Nephrological Diseases
  • 7.3. Drug Testing

8. Immunohistochemistry Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. CROs
  • 8.4. Forensic Labs
  • 8.5. Hospitals & Diagnostic Laboratories
  • 8.6. Pharma & Biopharma Companies

9. Americas Immunohistochemistry Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Immunohistochemistry Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Immunohistochemistry Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Abcam PLC
  • 13.2. Agilent Technologies, Inc.
  • 13.3. Bio SB, Inc.
  • 13.4. Bio-Rad Laboratories, Inc.
  • 13.5. Biocare Medical, LLC
  • 13.6. Biogenex Laboratories
  • 13.7. Candor Bioscience GmbH
  • 13.8. Cell Signaling Technology, Inc.
  • 13.9. Danaher Corporation
  • 13.10. Diagnostic BioSystems Inc.
  • 13.11. Eagle Biosciences, Inc.
  • 13.12. F. Hoffmann-La Roche AG
  • 13.13. GenomeMe
  • 13.14. Merck KGaA
  • 13.15. Miltenyi Biotec
  • 13.16. NeoGenomics Laboratories, Inc.
  • 13.17. Perkinelmer, Inc.
  • 13.18. Sakura Finetek Japan Co.,Ltd.
  • 13.19. Sino Biological Inc.
  • 13.20. Thermo Fisher Scientific, Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 11. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, 2018-2026 (USD MILLION)
  • FIGURE 40. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, 2018-2026 (USD MILLION)
  • FIGURE 42. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, 2018-2026 (USD MILLION)
  • FIGURE 44. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 45. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, 2018-2026 (USD MILLION)
  • FIGURE 46. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 47. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 48. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 50. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 51. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 53. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 54. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, 2018-2026 (USD MILLION)
  • FIGURE 55. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 56. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 57. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 58. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, 2018-2026 (USD MILLION)
  • FIGURE 59. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 60. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 61. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 62. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 63. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 64. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, 2018-2026 (USD MILLION)
  • FIGURE 65. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 66. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 67. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2026
  • FIGURE 69. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
  • FIGURE 70. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 71. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, 2018-2026 (USD MILLION)
  • FIGURE 72. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 73. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, 2018-2026 (USD MILLION)
  • FIGURE 74. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 75. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2026 (USD MILLION)
  • FIGURE 76. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 77. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, 2018-2026 (USD MILLION)
  • FIGURE 78. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 79. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 80. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 81. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 82. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 84. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 86. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 87. CALIFORNIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 88. FLORIDA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 89. ILLINOIS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 90. NEW YORK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 91. OHIO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 92. PENNSYLVANIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 93. TEXAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 94. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 95. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 96. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 97. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 98. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 99. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 100. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 101. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 102. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 103. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 104. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 107. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 108. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 109. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 110. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 111. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 112. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 113. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 114. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 115. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 116. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 117. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 118. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 119. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: FPNV POSITIONING MATRIX
  • FIGURE 120. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 121. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 122. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. CALIFORNIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. CALIFORNIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. CALIFORNIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. FLORIDA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. FLORIDA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. FLORIDA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. ILLINOIS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. ILLINOIS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. ILLINOIS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. NEW YORK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. NEW YORK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. NEW YORK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. OHIO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. OHIO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. OHIO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. PENNSYLVANIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. PENNSYLVANIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. PENNSYLVANIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. TEXAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. TEXAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. TEXAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: SCORES
  • TABLE 144. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: BUSINESS STRATEGY
  • TABLE 145. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: PRODUCT SATISFACTION
  • TABLE 146. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: RANKING
  • TABLE 147. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 148. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: SHARE, BY COMPANY, 2020
  • TABLE 149. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: MERGER & ACQUISITION
  • TABLE 150. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 151. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 152. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: INVESTMENT & FUNDING
  • TABLE 153. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 154. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: LICENSE & PRICING
  • TABLE 155. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: CONTACT DETAILS